Diagnostic Role of Anti-Saccharomyces cerevisiae and Antineutrophil Cytoplasmic Autoantibodies in Pediatric Inflammatory Bowel Disease.
- Author:
Jeong Eun KIM
1
;
Kyo Sun KIM
;
Jeong Kee SEO
Author Information
1. Department of Pediatrics, Konkuk University College of Medicine, Korea. jkseo@snu.ac.kr
- Publication Type:Original Article ; English Abstract
- Keywords:
Antibodies;
antineutrophil cytoplasmic;
Anti-Saccharomyces cereviseae mannan antibodies;
Inflammatory bowel diseases;
Child
- MeSH:
Adolescent;
Antibodies, Antineutrophil Cytoplasmic/*analysis;
Antibodies, Fungal/*analysis;
Child;
Child, Preschool;
Colitis, Ulcerative/*diagnosis;
Crohn Disease/*diagnosis;
Enzyme-Linked Immunosorbent Assay;
Female;
Fluorescent Antibody Technique;
Humans;
Male;
Mannans/immunology;
Predictive Value of Tests;
Saccharomyces cerevisiae/*immunology;
Sensitivity and Specificity
- From:The Korean Journal of Gastroenterology
2003;42(4):297-302
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND/AIMS: Combined measurement of perinuclear antineutrophil cytoplasmic autoantibodies (pANCA) and anti-Saccharomyces cereviseae mannan antibodies (ASCA) has recently been suggested as a valuable diagnostic approach to inflammatory bowel disease (IBD) in the pediatric age group. The aim of this study was to test the accuracy of the assay using pANCA and ASCA in diagnosing pediatric ulcerative colitis (UC) and Crohn's disease (CD). METHODS: Sera were collected from 25 patients with IBD (17 with CD, 8 with UC) and 32 healthy controls. The levels of pANCA and ASCA were determined by using a standard indirect immunofluorescence technique on ethanol-fixed granulocytes and an ELISA assay, respectively. RESULTS: In patients with UC, the sensitivity, specificity, and positive predictive value of the pANCA test were 38%, 88%, and 60%, respectively. Such values were not changed significantly in the case of positive pANCA and negative ASCA. The sensitivity, specificity, and positive predictive value of ASCA test in diagnosing CD were 71%, 88%, and 92%, respectively. The combination of pANCA negative and ASCA positive was not significant. CONCLUSIONS: ASCA and pANCA assays are highly disease specific for CD and UC, respectively. These serological tests can assist clinicians in diagnosing and categorizing patients with IBD and may be useful in making therapeutic decisions.